Molecular structure of low density lipoprotein: current status and future challenges
- PMID: 18797861
- DOI: 10.1007/s00249-008-0368-y
Molecular structure of low density lipoprotein: current status and future challenges
Abstract
This review highlights recent advances in structural studies on low density lipoprotein (LDL) with particular emphasis on the apolipoprotein moiety of LDL, apolipoprotein B100 (apoB100). Various molecular aspects of LDL are outlined and obstacles to structure determination are addressed. In this context, the prevailing conceptions of the molecular assembly of LDL and how the synergy of complementary biochemical, biophysical and molecular simulation approaches has lead to the current structural model of LDL are discussed. Evidence is presented that structural heterogeneity and the intrinsic dynamics of LDL are key determinants of the functionality of LDL in both health and disease. Some key research directions, remaining open questions and rapidly emerging new concepts for medical applications of LDL, are furthermore outlined. The article concludes by providing an outlook concerning promising future strategies for the clarification of the molecular details of LDL, in particular of apoB100, combining recent advances in molecular modeling with developments of novel experimental techniques. Although new insights into the molecular organization of LDL are forthcoming, many open questions remain unanswered. The major challenge of the next decade will certainly be the elucidation of the molecular structural and dynamic features of apoB100.
Similar articles
-
Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor.Nature. 2025 Feb;638(8051):829-835. doi: 10.1038/s41586-024-08223-0. Epub 2024 Dec 11. Nature. 2025. PMID: 39663455
-
The structure of apolipoprotein B100 from human low-density lipoprotein.Nature. 2025 Feb;638(8051):836-843. doi: 10.1038/s41586-024-08467-w. Epub 2024 Dec 11. Nature. 2025. PMID: 39662503 Free PMC article.
-
Theoretical model of human apolipoprotein B100 tertiary structure.Proteins. 2007 Feb 1;66(2):342-58. doi: 10.1002/prot.21229. Proteins. 2007. PMID: 17109403
-
Apolipoprotein B and low-density lipoprotein structure: implications for biosynthesis of triglyceride-rich lipoproteins.Adv Protein Chem. 1994;45:205-48. doi: 10.1016/s0065-3233(08)60641-5. Adv Protein Chem. 1994. PMID: 8154370 Review.
-
Evolving concepts of low-density lipoprotein: From structure to function.Eur J Clin Invest. 2025 May;55(5):e70019. doi: 10.1111/eci.70019. Epub 2025 Mar 5. Eur J Clin Invest. 2025. PMID: 40045739 Review.
Cited by
-
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.Curr Med Chem. 2015;22(31):3631-51. doi: 10.2174/0929867322666150716114625. Curr Med Chem. 2015. PMID: 26180001 Free PMC article. Review.
-
Structural changes induced by acidic pH in human apolipoprotein B-100.Sci Rep. 2016 Nov 8;6:36324. doi: 10.1038/srep36324. Sci Rep. 2016. PMID: 27824107 Free PMC article.
-
Effect of oxidation on the structure of human low- and high-density lipoproteins.Biophys J. 2014 Jun 17;106(12):2595-605. doi: 10.1016/j.bpj.2014.04.049. Biophys J. 2014. PMID: 24940777 Free PMC article.
-
Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.PLoS Pathog. 2014 Sep 4;10(9):e1004353. doi: 10.1371/journal.ppat.1004353. eCollection 2014 Sep. PLoS Pathog. 2014. PMID: 25188225 Free PMC article.
-
Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein.Hybridoma (Larchmt). 2012 Apr;31(2):87-98. doi: 10.1089/hyb.2011.0058. Hybridoma (Larchmt). 2012. PMID: 22509912 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources